Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
2d
GlobalData on MSNLineage begins study of OPC1 delivering device for spinal cord injury treatmentAn allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...
The steering committee for SFO stem cells and regenerative medicine has decided to award 6 senior research grants for 2025 and 2026. Each grant has a value of 2 million SEK per year. We aim to develop ...
Introducing a 2010 NXi Platform Phenom 100. Served its purposes for the current owner, who is now looking to transition their aviation platform. Call Jordan at (231) 578-3942 for more information.
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, China (X. Han, Y.L., L.S., B.H., B.Z.). CAS CEMCS-CUHK Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results